业务
货币单位:美元
2023/FY
名称营收比例
肿瘤学/免疫学5.29亿63.08%
其他风险投资3.09亿36.92%
地区
货币单位:美元
2023/FY
名称营收比例
Research and Development (R&D) U.S. and Others3.46亿41.28%
其他风险投资，中国内地3.09亿36.92%
市售产品，中国内地1.57亿18.74%
Research and Development (R&D) People's Republic of China1,849.2万2.21%
Marketed Products U.S. and Others714.5万0.85%
